Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 2861 | 14.54 |
09:34 ET | 1793 | 14.04 |
09:36 ET | 100 | 14.045 |
09:38 ET | 763 | 13.82 |
09:39 ET | 1102 | 13.85 |
09:41 ET | 1036 | 13.95 |
09:43 ET | 1288 | 13.84 |
09:45 ET | 600 | 13.82 |
09:48 ET | 300 | 13.66 |
09:50 ET | 400 | 13.67 |
09:52 ET | 4135 | 13.82 |
09:54 ET | 350 | 13.87 |
09:56 ET | 3861 | 13.88 |
09:57 ET | 200 | 13.88 |
09:59 ET | 100 | 13.825 |
10:01 ET | 3423 | 13.965 |
10:06 ET | 3243 | 14.03 |
10:08 ET | 100 | 14.07 |
10:10 ET | 1650 | 14.01 |
10:12 ET | 1802 | 14.005 |
10:14 ET | 237 | 14.01 |
10:15 ET | 169 | 14.01 |
10:17 ET | 300 | 14.04 |
10:19 ET | 23810 | 14.08 |
10:21 ET | 16563 | 14.115 |
10:24 ET | 900 | 14.12 |
10:26 ET | 300 | 14.16 |
10:28 ET | 2351 | 14.02 |
10:30 ET | 100 | 14.01 |
10:32 ET | 2168 | 14.045 |
10:33 ET | 2239 | 14.05 |
10:35 ET | 3070 | 14.12 |
10:37 ET | 601 | 14.1 |
10:39 ET | 1734 | 14.1 |
10:42 ET | 2421 | 14.22 |
10:44 ET | 2244 | 14.27 |
10:48 ET | 2830 | 14.335 |
10:50 ET | 2196 | 14.39 |
10:51 ET | 4563 | 14.435 |
10:53 ET | 1218 | 14.4329 |
10:55 ET | 2406 | 14.43 |
10:57 ET | 1127 | 14.41 |
11:00 ET | 1137 | 14.43 |
11:02 ET | 2905 | 14.4 |
11:04 ET | 3350 | 14.3 |
11:06 ET | 500 | 14.29 |
11:08 ET | 1017 | 14.28 |
11:09 ET | 2643 | 14.34 |
11:11 ET | 100 | 14.33 |
11:13 ET | 7823 | 14.31 |
11:15 ET | 100 | 14.335 |
11:18 ET | 3637 | 14.41 |
11:20 ET | 11042 | 14.37 |
11:24 ET | 2591 | 14.33 |
11:26 ET | 12615 | 14.2 |
11:27 ET | 675 | 14.195 |
11:29 ET | 3115 | 14.21 |
11:31 ET | 1926 | 14.17 |
11:33 ET | 3241 | 14.175 |
11:36 ET | 1410 | 14.13 |
11:38 ET | 3479 | 14.21 |
11:40 ET | 2096 | 14.17 |
11:42 ET | 700 | 14.16 |
11:44 ET | 1238 | 14.15 |
11:45 ET | 1021 | 14.15 |
11:47 ET | 378 | 14.14 |
11:49 ET | 1300 | 14.15 |
11:51 ET | 1913 | 14.195 |
11:54 ET | 1600 | 14.215 |
11:56 ET | 1200 | 14.215 |
11:58 ET | 514 | 14.215 |
12:00 ET | 1717 | 14.215 |
12:02 ET | 5625 | 14.21 |
12:03 ET | 2024 | 14.23 |
12:05 ET | 2446 | 14.25 |
12:07 ET | 1212 | 14.23 |
12:09 ET | 1938 | 14.25 |
12:12 ET | 5922 | 14.3 |
12:14 ET | 1888 | 14.31 |
12:16 ET | 1450 | 14.28 |
12:18 ET | 4506 | 14.33 |
12:20 ET | 1599 | 14.345 |
12:21 ET | 1538 | 14.33 |
12:23 ET | 3931 | 14.31 |
12:25 ET | 1630 | 14.3 |
12:27 ET | 849 | 14.29 |
12:30 ET | 2500 | 14.295 |
12:32 ET | 3101 | 14.335 |
12:34 ET | 1479 | 14.4125 |
12:36 ET | 2405 | 14.515 |
12:38 ET | 300 | 14.56 |
12:39 ET | 1700 | 14.6 |
12:41 ET | 1550 | 14.61 |
12:43 ET | 900 | 14.62 |
12:45 ET | 2843 | 14.56 |
12:48 ET | 1068 | 14.58 |
12:50 ET | 1677 | 14.57 |
12:52 ET | 851 | 14.56 |
12:54 ET | 713 | 14.6 |
12:56 ET | 769 | 14.65 |
12:57 ET | 3162 | 14.58 |
12:59 ET | 1923 | 14.61 |
01:01 ET | 733 | 14.62 |
01:03 ET | 2912 | 14.57 |
01:06 ET | 956 | 14.555 |
01:08 ET | 2114 | 14.59 |
01:10 ET | 942 | 14.59 |
01:12 ET | 927 | 14.605 |
01:14 ET | 1185 | 14.63 |
01:15 ET | 917 | 14.605 |
01:17 ET | 590 | 14.61 |
01:19 ET | 1400 | 14.66 |
01:21 ET | 6057 | 14.56 |
01:24 ET | 500 | 14.56 |
01:26 ET | 1297 | 14.515 |
01:28 ET | 4023 | 14.53 |
01:30 ET | 300 | 14.59 |
01:32 ET | 1752 | 14.54 |
01:33 ET | 1206 | 14.565 |
01:35 ET | 400 | 14.61 |
01:37 ET | 2499 | 14.57 |
01:39 ET | 1952 | 14.5275 |
01:42 ET | 2197 | 14.5 |
01:44 ET | 1320 | 14.485 |
01:46 ET | 2710 | 14.52 |
01:48 ET | 2257 | 14.46 |
01:50 ET | 7807 | 14.39 |
01:51 ET | 200 | 14.385 |
01:53 ET | 300 | 14.37 |
01:55 ET | 2344 | 14.35 |
01:57 ET | 968 | 14.35 |
02:00 ET | 3202 | 14.345 |
02:02 ET | 699 | 14.345 |
02:04 ET | 650 | 14.33 |
02:06 ET | 3483 | 14.355 |
02:08 ET | 3689 | 14.355 |
02:09 ET | 3402 | 14.29 |
02:11 ET | 387 | 14.27 |
02:13 ET | 783 | 14.25 |
02:15 ET | 1800 | 14.255 |
02:18 ET | 2169 | 14.23 |
02:20 ET | 2115 | 14.26 |
02:22 ET | 100 | 14.275 |
02:24 ET | 2736 | 14.21 |
02:26 ET | 487 | 14.19 |
02:27 ET | 1387 | 14.18 |
02:29 ET | 820 | 14.17 |
02:31 ET | 989 | 14.19 |
02:33 ET | 3046 | 14.19 |
02:36 ET | 2796 | 14.24 |
02:38 ET | 7828 | 14.3325 |
02:40 ET | 659 | 14.31 |
02:42 ET | 3584 | 14.33 |
02:44 ET | 1758 | 14.31 |
02:45 ET | 1585 | 14.29 |
02:47 ET | 1132 | 14.3 |
02:49 ET | 7381 | 14.32 |
02:51 ET | 3873 | 14.35 |
02:54 ET | 1364 | 14.31 |
02:56 ET | 1870 | 14.3325 |
02:58 ET | 1144 | 14.3 |
03:00 ET | 12123 | 14.3 |
03:02 ET | 15676 | 14.325 |
03:03 ET | 7698 | 14.345 |
03:05 ET | 2684 | 14.33 |
03:07 ET | 4027 | 14.28 |
03:09 ET | 1107 | 14.24 |
03:12 ET | 5421 | 14.22 |
03:14 ET | 1894 | 14.275 |
03:16 ET | 1725 | 14.285 |
03:18 ET | 3093 | 14.23 |
03:20 ET | 1700 | 14.25 |
03:21 ET | 1939 | 14.21 |
03:23 ET | 1728 | 14.17 |
03:25 ET | 1374 | 14.13 |
03:27 ET | 1326 | 14.12 |
03:30 ET | 3527 | 14.19 |
03:32 ET | 3152 | 14.19 |
03:34 ET | 19801 | 14.265 |
03:36 ET | 2347 | 14.2 |
03:38 ET | 2268 | 14.11 |
03:39 ET | 2186 | 14.17 |
03:41 ET | 5105 | 14.13 |
03:43 ET | 2655 | 14.12 |
03:45 ET | 3284 | 14.2 |
03:48 ET | 4837 | 14.17 |
03:50 ET | 4040 | 14.16 |
03:52 ET | 6917 | 14.18 |
03:54 ET | 9841 | 14.06 |
03:56 ET | 9019 | 14.04 |
03:57 ET | 11577 | 14.08 |
03:59 ET | 123693 | 14.08 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 501.7M | -4.2x | --- |
Savara Inc | 505.5M | -13.4x | --- |
Entrada Therapeutics Inc | 496.7M | -5.8x | --- |
GH Research PLC | 509.8M | -14.3x | --- |
Dyne Therapeutics Inc | 529.0M | -2.5x | --- |
WAVE Life Sciences Ltd | 525.6M | -3.9x | --- |
Biomea Fusion, Inc. is a preclinical-stage biopharmaceutical company. The Company is focused on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. The Company has built FUSION System discovery platform to advance a pipeline of covalent small molecule product candidates. The Company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective covalent inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The Company is developing BMF-219 for the treatment of liquid and solid tumors that are dependent on menin, including leukemias containing the mixed lineage leukemia (MLL) fusion protein. The Company is also advancing other preclinical covalent programs for the treatment of select cancers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $501.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.33 |
Book Value | $3.67 |
P/E Ratio | -4.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.